What question did this study set out to answer?

This research aims to explore the relationship between serum endocan levels and cardiovascular risk factors in systemic lupus erythematosus (SLE).

March 12, 2026International Journal of Rheumatic Diseases1 citations

Serum Endocan in Systemic Lupus Erythematosus: Implication for Endothelial Dysfunction and Cardiovascular Risk

This research aims to explore the relationship between serum endocan levels and cardiovascular risk factors in systemic lupus erythematosus (SLE).
Measured serum endocan levels in SLE patients
Assessed endothelial function
Evaluated subclinical atherosclerosis
Elevated serum endocan levels were observed in SLE patients
These levels correlated with signs of endothelial dysfunction
Findings suggest an increased cardiovascular risk in this population

Elevated serum levels of endocan in SLE patients may be associated with subclinical atherosclerosis and endothelial dysfunction.

KI fragen

Bookmark

View Full Paper

KI fragen

Bookmark

View Full Paper